Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)

CAPS Rating: 4 out of 5

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.

Recs

1
Player Avatar jatt22 (40.91) Submitted: 9/15/2009 10:13:34 AM : Outperform Start Price: $13.56 LGND Score: -31.60

just bought in real P F

Featured Broker Partners


Advertisement